MY147641A - Fast release paracetamol tablets - Google Patents

Fast release paracetamol tablets

Info

Publication number
MY147641A
MY147641A MYPI20083952A MYPI20083952A MY147641A MY 147641 A MY147641 A MY 147641A MY PI20083952 A MYPI20083952 A MY PI20083952A MY PI20083952 A MYPI20083952 A MY PI20083952A MY 147641 A MY147641 A MY 147641A
Authority
MY
Malaysia
Prior art keywords
fast release
paracetamol tablets
release paracetamol
tablets
exlragranular
Prior art date
Application number
MYPI20083952A
Inventor
Hemant H Alur
Original Assignee
GlaxoSmithKline Consumer Healthcare UK IP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Consumer Healthcare UK IP Ltd filed Critical GlaxoSmithKline Consumer Healthcare UK IP Ltd
Publication of MY147641A publication Critical patent/MY147641A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A PHARMACEUTICAL COMPOSITION SUCH AS A SWALLOW TABLET OR CAPSULE FORMULATION IS DESCRIBED COMPRISING PARACETAMOL, CALCIUM CARBONATE, AT LEAST ONE BINDING AGENT AND AT LEAST ONE DISINTEGRATING AGENT IN THE FORM OF A GRANULATE, OPTIONALLY COMBINED WITH ONE OR MORE PHARMACEUTICALLY ACCEPTABLE EXLRAGRANULAR COMPONENTS.
MYPI20083952A 2006-04-07 2008-10-03 Fast release paracetamol tablets MY147641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0607085.8A GB0607085D0 (en) 2006-04-07 2006-04-07 Novel compositions

Publications (1)

Publication Number Publication Date
MY147641A true MY147641A (en) 2012-12-31

Family

ID=36539581

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20083952A MY147641A (en) 2006-04-07 2008-10-03 Fast release paracetamol tablets

Country Status (15)

Country Link
US (1) US8461210B2 (en)
EP (1) EP2010159B1 (en)
CN (1) CN101466359B (en)
AU (1) AU2007234864B2 (en)
BR (1) BRPI0709847B8 (en)
CA (1) CA2648725A1 (en)
CR (1) CR10349A (en)
DK (1) DK2010159T3 (en)
EA (1) EA017157B1 (en)
GB (1) GB0607085D0 (en)
MX (1) MX2008012731A (en)
MY (1) MY147641A (en)
NO (1) NO20084065L (en)
NZ (1) NZ571624A (en)
WO (1) WO2007118063A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
ES2712989T3 (en) 2009-10-30 2019-05-17 Ix Biopharma Ltd Fast dissolving solid dosage form
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
WO2011135106A1 (en) * 2010-04-26 2011-11-03 Smart Pharma Solutions, S.L Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for the obtainment thereof
US9446000B2 (en) * 2011-09-08 2016-09-20 Masdar Institute Of Science And Technology Cellulosic gel material as a pharmaceutical excipient
US20140128415A1 (en) * 2012-05-30 2014-05-08 Paul Daniel Yered Excipient drug composition
CN103110637B (en) * 2013-02-19 2014-07-30 青岛正大海尔制药有限公司 Paracetamol capsules and preparation method thereof
BE1021194B1 (en) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba PARACETAMOL TABLETS
CN105310990B (en) * 2014-12-04 2018-01-19 蚌埠丰原涂山制药有限公司 It is a kind of prevent sticking and sliver to acetyl ammonia phenol piece and preparation method thereof
BE1023116B1 (en) * 2015-07-24 2016-11-23 Nordic Specialty Pharma Bvba PARACETAMOL COMPRISING PREPARATION WITH DELAYED AND CONTINUOUS ISSUE
CN105055329A (en) * 2015-08-05 2015-11-18 安丘市鲁安药业有限责任公司 Composite paracetamol instant particle and preparation method thereof
CN106265573A (en) * 2016-09-23 2017-01-04 广东岭南职业技术学院 The preparation technology of HPMC slurry in the production of a kind of paracetamol tablet
CN108451916B (en) * 2018-06-19 2020-08-14 重庆国泰康宁制药有限责任公司 Acetaminophen pharmaceutical composition preparation and preparation method thereof
CN108853038A (en) * 2018-08-06 2018-11-23 成都通德药业有限公司 A kind of paracetamol tablets and its preparation process
CN111374953A (en) * 2018-12-31 2020-07-07 上海鼎雅药物化学科技有限公司 Acetaminophen tablet and preparation process thereof
EP3679926A1 (en) * 2019-01-14 2020-07-15 APTYS Pharmaceuticals SAS A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby
CN110101672A (en) * 2019-05-07 2019-08-09 安徽金太阳生化药业有限公司 A kind of paracetamol tablets and preparation method thereof
CN111012750A (en) * 2019-12-27 2020-04-17 北京济美堂医药研究有限公司 Paracetamol tablet and preparation method thereof
GB202007670D0 (en) 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition
CN114129524A (en) * 2021-09-30 2022-03-04 山东齐都药业有限公司 Paracetamol tablet and preparation method thereof
CN114432256A (en) * 2021-12-31 2022-05-06 陕西必康制药集团控股有限公司 Paracetamol coated tablet and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
CA2009326C (en) * 1989-05-09 1998-01-27 Lawrence J. Daher Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2566331C (en) 2004-05-28 2011-03-15 Imaginot Pty Ltd. Oral delivery system
ES2624585T3 (en) 2004-05-28 2017-07-17 Imaginot Pty Ltd. Oral therapeutic compound delivery system
DE602005020048D1 (en) 2004-10-28 2010-04-29 Novartis Ag COMPOSITION WITH ACETAMINOPHES, CAFFEINE AND ASPIRINE TOGETHER WITH AN ALKALINE FOR IMPROVED ABSORPTION
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system

Also Published As

Publication number Publication date
CA2648725A1 (en) 2007-10-18
AU2007234864B2 (en) 2012-11-22
US20090170955A1 (en) 2009-07-02
BRPI0709847A2 (en) 2011-07-26
NO20084065L (en) 2008-10-30
AU2007234864A1 (en) 2007-10-18
CN101466359B (en) 2013-09-25
WO2007118063A1 (en) 2007-10-18
US8461210B2 (en) 2013-06-11
EA200801926A1 (en) 2009-04-28
EP2010159B1 (en) 2012-08-22
GB0607085D0 (en) 2006-05-17
CR10349A (en) 2008-11-26
DK2010159T3 (en) 2012-10-22
NZ571624A (en) 2011-11-25
EP2010159A1 (en) 2009-01-07
MX2008012731A (en) 2008-10-14
EA017157B1 (en) 2012-10-30
BRPI0709847B1 (en) 2020-09-15
BRPI0709847B8 (en) 2021-05-25
CN101466359A (en) 2009-06-24

Similar Documents

Publication Publication Date Title
MY147641A (en) Fast release paracetamol tablets
IL181382A0 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
AU2010308458A8 (en) Orally transformable tablets
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
MX343358B (en) Ulipristal acetate tablets.
WO2008014175A3 (en) Granular pharmaceutical compositions
TN2009000093A1 (en) Pharmaceutical compositions comprising nilotinib or its salt
UA100403C2 (en) Capsule formulation
IL187475A (en) Oral solid dosage form comprising a first population of microparticles for the modified release of at least one analgesic active principle and a second population of microparticles containing at least one quenching agent and uses thereof
WO2007143155A3 (en) Sustained release pharmaceutical dosage form containing phenylephrine
MX2010007083A (en) Anti - retroviral combination.
MX2009006056A (en) Ph sensitive matrix formulation.
MX2011011928A (en) Method and composition to improve absorption of therapeutic agents.
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
WO2008005353A3 (en) Immediate-release tablet formulations of a thrombin receptor antagonist
MX2007002898A (en) Tablets with site time-controlled gastrointestinal release of active ingredient.
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
WO2007099555A3 (en) Pharmaceutical tablet compositions containing irbesartan
WO2008038155A3 (en) Controlled-release pharmaceutical tablets
ZA200506992B (en) Fibrate tablet and method for the production thereof
PT1499278E (en) IMMEDIATE RELEASE PHARMACEUTICAL FORM FOR COMPOSITION OF TIBOLONE POLYMER
EA200601283A1 (en) PHARMACEUTICAL COMPOSITION WITH CONTROLLED SURVIVAL, CONTAINING INSOLUBLE IN ACIDS POLYMER AND BIOADHESIVE POLYMER